Medical devices developer CH Biomedical Inc has closed a Series D round of financing led by tech bellwether Sequoia Capital China.
Other new investors who participated in the round include Lake Bleu Capital, Linden Asset Group and Longmen Capital, while return backers namely Baheal Pharmaceutical and HosenCare Brothers re-upped in the round.
CH Biomedical is a high-end medical equipment producer of ventricular assist devices to increase blood flow through the body.
CH Biomedical had earlier secured six other rounds of financing from Oriza Seed, FC Capital, Share Capital, XIYEE Asset, among others.
CHINA DEAL MONITOR
DealStreetAsia has also put together a table listing out all prominent venture capital transactions in the Greater China region from August 12 – 13, 2021.
